Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;24(11):1461-1475.
doi: 10.1007/s11912-022-01319-8. Epub 2022 Aug 12.

Interventional Management of Portal Hypertension in Cancer Patients

Max Kabolowsky  1 , Lyndsey Nguyen  2 , Brett E Fortune  3 , Ernesto Santos  4 , Sirish Kishore  5 , Juan C Camacho  6
Affiliations
Review

Interventional Management of Portal Hypertension in Cancer Patients

Max Kabolowsky et al. Curr Oncol Rep. 2022 Nov.

Abstract

Purpose of review: To provide an overview of the classifications and clinical hallmarks of common cancer-related conditions that contribute to the high incidence of portal hypertension in this population and provide an update on currently available interventional radiology therapeutic approaches.

Recent findings: In the last few decades, there have been significant advancements in understanding the pathophysiology of portal hypertension. This knowledge has led to the development of safer and more effective minimally invasive approaches. The main objective is to provide alternatives to prevent life-threatening complications from clinically significant portal hypertension and to allow the continuation of cancer treatment interventions that would otherwise be stopped. Clinicians involved in cancer care should be aware of risk factors, associated complications, and management of portal hypertension in cancer patients. Interventional radiology offers minimally invasive alternatives that play a central role in improving clinical outcomes and survival of these patients, allowing the continuation of cancer treatments.

Keywords: Ascites; Cancer; Interventional radiology; Non-cirrhotic portal hypertension; Portal hypertension; Variceal bleeding.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. • Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W. Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open. 2016;1(2):e000042-e. doi: https://doi.org/10.1136/esmoopen-2016-000042 . Good review establishing the clear relationship between cancer and PH.
    1. Khanna R, Sarin SK. Noncirrhotic portal hypertension: current and emerging perspectives. Clin Liver Dis. 2019;23(4):781–807. https://doi.org/10.1016/j.cld.2019.07.006 . - PubMed
    1. Manenti A, Forghieri F, Colasanto D, MarioLuppi. Splenomegaly secondary to myeloproliferative neoplasms and portal hypertension. Clin Lymphoma Myeloma Leuk. 2015;15(6):e135. doi: https://doi.org/10.1016/j.clml.2014.10.005 .
    1. Weston CJ, Zimmermann HW, Adams DH. The role of myeloid-derived cells in the progression of liver disease. Front Immunol. 2019;10:893-. doi: https://doi.org/10.3389/fimmu.2019.00893 .
    1. Mier-Hicks A, Raj M, Do RK, Yu KH, Lowery MA, Varghese A, et al. Incidence, Management, and Implications of Visceral Thrombosis in pancreatic ductal adenocarcinoma. Clin Colorectal Cancer. 2018;17(2):121–8. https://doi.org/10.1016/j.clcc.2018.01.008 . - PubMed

MeSH terms

LinkOut - more resources